INTERPACE BIOSCIENCES, INC. (IDXG)

SEC filing

INTERPACE BIOSCIENCES, INC.

IDXG · CIK 1054102

4 · Aug 20, 2026 · Director, CEO, President & Chairman Burnell Thomas W. exercised options for 3.93M shares; was granted 2.52M shares; reported 581.72K shares

Director, CEO, President & Chairman Burnell Thomas W. exercised options for 3.93M shares; was granted 2.52M shares; reported 581.72K shares

Filed: Aug 20, 2026
Period: Aug 20, 2026
Accession: 0001493152-26-039528
Filer: INTERPACE BIOSCIENCES, INC.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov